Rb Capital Management, LLC Akebia Therapeutics, Inc. Transaction History

Rb Capital Management, LLC

  • $408 Million
  • Q1 2025

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023
BUY
$0.51 - $1.43 $5,100 - $14,300
10,000 New
10,000 $9,000

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $542M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Rb Capital Management, LLC Portfolio

Follow Rb Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rb Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email